P-cadherin | |||
---|---|---|---|
Variable | Low | High | P-value |
Age, mean ± SD (years) | 55.8 ± 11.5 | 55.7 ± 12.9 | .428 |
PS (no.) | .627 | ||
0 | 52 | 67 | |
1 | 11 | 20 | |
2 or 3 | 4 | 8 | |
CA125 a(no.) | .262 | ||
≤136 | 37 | 42 | |
> 136 | 30 | 51 | |
NA | 0 | 2 | |
Stage b(FIGO2014) (no.) | .0024* | ||
Stage I/II | 46 | 42 | |
Stage III/IV | 21 | 53 | |
Peritoneal dissemination (no.) | 2.7e-5* | ||
Positive | 18 | 58 | |
Negative | 49 | 37 | |
Lymph node metastasis b(no.) | .823 | ||
Positive | 9 | 15 | |
Negative | 58 | 80 | |
Distant site metastasis (no.) | .048* | ||
Positive | 1 | 9 | |
Negative | 65 | 86 | |
Histologic typeb (no.) | 1.37e-10* | ||
Clear cell | 30 | 4 | |
Endometrioid | 9 | 21 | |
Mucinous | 12 | 11 | |
Serous | 16 | 59 |